Amylyx Pharmaceuticals | The Optimist Daily: Making Solutions the News
Today’s Solutions: July 14, 2024

Successful trial of new drug b

Successful trial of new drug brings ALS treatment closer to FDA approval

Amyotrophic lateral sclerosis (ALS) is a degenerative neurological condition, but there may soon be another treatment option for the disease as Amylyx Pharmaceuticals finishes successful phase 2 of human trials and moves into phase 3 of a new experimental drug.  The new treatment, called Read More...